SN

Shanti Naik

Director Director DIN 01824620
DIN 01824620 First appointment Nov 2005 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Nov 2005
Shareholding value •••• Premium profile

About Shanti Naik

Data last updated:

Shanti Naik was a Director at Datsun Pharmaceuticals Private Limited (2005–2011) and Director at Datsun Shipping Private Limited (Opc) (2005–2019). The companies operate in Pharma and Transportation.

DIN 01824620
Primary Designation Director
Industry Pharma
First Appointment 21 Nov 2005

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Nov 20052000Active
Director21 Nov 20051997₹23 Lakh (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Datsun Pharmaceuticals Private Limited
Datsun Shipping Private Limited (Opc)
Premium access

Shareholding and investment profile for Shanti Naik

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shanti Naik

Shanti Naik was first appointed on 21 Nov 2005 as Director at Datsun Pharmaceuticals Private Limited.

Shanti Naik held 2 earlier board appointments: Datsun Pharmaceuticals Private Limited (Director, 21 Nov 2005 to 07 May 2011); Datsun Shipping Private Limited (Opc) (Director, 21 Nov 2005 to 27 May 2019).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available